JPMorgan Chase Financial Co. LLC has filed a preliminary pricing supplement for structured investments linked to the MerQube US Tech+ Vol Advantage Index due November 28, 2031. This filing is significant as it reflects the company's ongoing strategy to diversify its investment offerings, catering to investors looking for unique financial products.
The filing, dated October 29, 2026, highlights the company's intent to broaden its portfolio in the national commercial banking sector. These structured notes are designed for investors who may seek an early exit prior to maturity at a premium, contingent on the performance of the underlying index.
Background
JPMorgan Chase Financial Co. LLC, a subsidiary of JPMorgan Chase & Co., operates under the Standard Industrial Classification (SIC) code 6021, which pertains to National Commercial Banks. The company is incorporated in Delaware and has its business address at 383 Madison Avenue, New York, NY. The firm has a fiscal year ending on December 31.
Recent filings from the company include multiple submissions on October 29, 2026, all categorized under Form 424B2, indicating a significant day for the firm in terms of regulatory disclosures.
What the Filing Says
The preliminary pricing supplement outlines key features of the structured notes, including the following:
- The notes are fully and unconditionally guaranteed by JPMorgan Chase & Co.
- Investors may receive a premium if the closing level of the MerQube US Tech+ Vol Advantage Index meets or exceeds the call value on review dates.
- The notes are unsecured and subject to the credit risk of both JPMorgan Chase Financial Co. LLC and JPMorgan Chase & Co.
- The minimum denomination for investment is set at $1,000.
Additionally, the notes will be subject to a 6.0% per annum daily deduction, which could impact the overall returns for investors.
Impact
This filing may affect various stakeholders, including current and potential investors looking for innovative investment opportunities within the national commercial banking industry. The structured notes present a unique offering that could attract a specific segment of investors willing to accept higher risks for the potential of higher returns.
What's Next
The notes are expected to price on or about November 24, 2026, with settlement anticipated on or about November 27, 2026. Investors and analysts will be closely watching these developments as they unfold.
For further details, the filing can be accessed through the SEC's EDGAR database under accession number 0001918704-26-033245.
Read Next
Workers United Files to Sell $8.4 Million in Amalgamated Stock
Carvana Co. files to sell 10 million shares of stock
Platford Giles Richard to Sell 55,617 Takeda Shares
Takeda's Teresa Bitetti to Sell 46,609 Shares Amid Tax Obligations
Kiniksa Pharmaceuticals reports significant stock sale by officer
Moat Ross to Sell Over 103,000 Shares of Kiniksa Pharmaceuticals










